Drugs / Poliomyelitis Vaccine inactivated
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 31 trial | ||||||
| Phase 3 | NCT00348387 | Jun 2006 → Sep 2008 | poliomyelitis | Sanofi Pasteur, a Sanofi Company | Completed | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT05163561 Comparator | Jan 2022 → Apr 2023 | poliomyelitis | Serum Institute of India Pvt. Ltd. | Completed | Met primary |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Poliomyelitis Vaccine inactivated | “Poliomyelitis Vaccine (Inactivated), produced by Serum Institute of India Pvt. Ltd., is a sterile suspension of three types of inactivated poliovirus: Type 1 (Mahoney), Type 2...” NCT05163561 ↗ |
| Modality | Vaccine | “Poliomyelitis Vaccine inactivated” NCT00348387 ↗ |
| Route | Intramuscular | “0.5 mL, Intramuscular” NCT00348387 ↗ |